Oppenheimer & Co. Inc. Has $2.32 Million Position in Blue Owl Capital Inc. $OWL

Oppenheimer & Co. Inc. grew its stake in shares of Blue Owl Capital Inc. (NYSE:OWL) by 185.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 136,956 shares of the company’s stock after acquiring an additional 88,935 shares during the period. Oppenheimer & Co. Inc.’s holdings in Blue Owl Capital were worth $2,319,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Alps Advisors Inc. boosted its position in Blue Owl Capital by 34.2% during the third quarter. Alps Advisors Inc. now owns 81,735 shares of the company’s stock valued at $1,384,000 after purchasing an additional 20,840 shares during the last quarter. Prime Capital Investment Advisors LLC acquired a new stake in shares of Blue Owl Capital during the 3rd quarter valued at about $194,000. M.D. Sass LLC grew its stake in shares of Blue Owl Capital by 24.4% in the 3rd quarter. M.D. Sass LLC now owns 292,271 shares of the company’s stock valued at $4,948,000 after buying an additional 57,326 shares in the last quarter. Bessemer Group Inc. grew its stake in shares of Blue Owl Capital by 20.3% in the 3rd quarter. Bessemer Group Inc. now owns 4,967 shares of the company’s stock valued at $84,000 after buying an additional 838 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S increased its holdings in Blue Owl Capital by 26.0% in the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 4,970 shares of the company’s stock worth $84,000 after buying an additional 1,027 shares during the last quarter. 35.85% of the stock is currently owned by hedge funds and other institutional investors.

Blue Owl Capital Price Performance

OWL stock opened at $12.48 on Friday. Blue Owl Capital Inc. has a 52-week low of $10.88 and a 52-week high of $24.28. The company has a 50-day moving average of $14.93 and a two-hundred day moving average of $16.39. The stock has a market capitalization of $19.46 billion, a price-to-earnings ratio of 124.81, a price-to-earnings-growth ratio of 1.01 and a beta of 1.11.

Blue Owl Capital (NYSE:OWL) last posted its quarterly earnings data on Thursday, February 5th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.02. Blue Owl Capital had a return on equity of 20.70% and a net margin of 2.75%.The business had revenue of $701.47 million for the quarter, compared to analyst estimates of $712.75 million. Equities analysts expect that Blue Owl Capital Inc. will post 0.92 EPS for the current fiscal year.

Blue Owl Capital Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 20th will be issued a dividend of $0.225 per share. The ex-dividend date is Friday, February 20th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 7.2%. Blue Owl Capital’s payout ratio is 900.00%.

Insiders Place Their Bets

In related news, CEO Douglas I. Ostrover bought 139,327 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was purchased at an average cost of $15.06 per share, for a total transaction of $2,098,264.62. Following the purchase, the chief executive officer directly owned 158,000 shares in the company, valued at $2,379,480. This trade represents a 746.14% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Alan Kirshenbaum purchased 33,670 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was bought at an average price of $14.87 per share, for a total transaction of $500,672.90. Following the completion of the transaction, the chief financial officer directly owned 33,670 shares in the company, valued at approximately $500,672.90. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 395,670 shares of company stock valued at $5,952,393 over the last ninety days. 27.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on OWL shares. UBS Group reduced their target price on shares of Blue Owl Capital from $18.00 to $16.50 and set a “neutral” rating for the company in a research note on Tuesday, January 13th. Raymond James Financial raised shares of Blue Owl Capital from a “market perform” rating to a “strong-buy” rating and set a $20.00 price objective for the company in a research note on Wednesday, December 10th. JPMorgan Chase & Co. increased their target price on shares of Blue Owl Capital from $21.50 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 29th. Citigroup restated an “outperform” rating on shares of Blue Owl Capital in a report on Tuesday, January 27th. Finally, Wolfe Research set a $20.00 price target on Blue Owl Capital in a research note on Wednesday, January 7th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $19.22.

Blue Owl Capital Profile

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.